| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |